Data Foundry

Drug recalls 2026

Olmesartan Medoxomil — Class II drug recall D-0077-2027

Ongoing recall by MACLEODS PHARMA USA, INC, reported 2026-11-04, distributed nationwide. Failed Dissolution Specifications.

Recall numberD-0077-2027
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmMACLEODS PHARMA USA, INC, Princeton, NJ, United States
Recall initiated2026-10-07
Classified2026-10-26
Reported by FDA2026-11-04
DistributedNationwide (US)
Reason classesspecification failure
NDC33342-0243, 33342-0243-07, 33342-0243-10, 33342-0244, 33342-0244-07, 33342-0244-10, 33342-0245, 33342-0245-07, 33342-0245-10, 33342-0246, 33342-0246-07, 33342-0246-10, 33342-0247, 33342-0247-07, 33342-0247-10
Expiration dates2027-05-31

Product

Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets 40 mg/10 mg/12.5mg, packaged as a) 30-count bottle, NDC 33342-246-07; b) 90-count bottle, NDC 33342-246-10; Rx Only, Manufactured for : Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd, Daman, 396210, India

Reason for recall

Failed Dissolution Specifications.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0077-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-10. Not affiliated with or endorsed by FDA. Not medical or legal advice.